Skip to main content

Robin Stears, Kevin Shutes, Robert Joss, Bernice Welles, Michael Sweeney, Arnold Oronsky, Gil Kliman

Premium

Robin Stears joins BioRad Laboratories of Hercules, Calif., as marketing manager, microarray business unit. Previously, Stears was senior scientist for Arrayit, the biotechnology division of TeleChem International of Sunnyvale, Calif. She also served as a microarray industry consultant to the healthcare division of Gerson Lehrman Group. Previously, Stears directed the gene expression profiling group for Adventis Pharmaceuticals. Stears holds PhD and BS degrees from the State University of New York at Stony Brook.

 

Kevin Shutes, previously the general manager, has been named president of the Celex wire and tube-cutting division of Point Technologies of Boulder, Colo., the company said last week. Celex manufactures Point Technologies microarray spotting pins.

 

Robert Joss, dean of the Graduate School of Business at Stanford University, has been named to the board of directors of Agilent Technologies, the company said last week. Before joining Stanford in 1999, Joss was chief executive officer and managing director of Westpac Banking, Australia’s second largest bank. Joss, 62, earned his MBA and PhD at Stanford University. He holds a BA in economics from the University of Washington.

 

Bernice Welles joins the San Francisco office of MPM BioVentures, the venture capital subsidiary of MPM Capital, which manages some $2.1 billion in capital, as a venture partner. She most recently served as vice president of product development at Genentech.

 

Michael Sweeney has been promoted to general partner of the VC firm InterWest Partners, and will co-lead the firm’s life sciences team with other general partners Arnold Oronsky and Gil Kliman, InterWest said July 15. Sweeney has been a venture partner at InterWest since 2001, and was entrepeneur in residence at the Menlo Park, Calif., and Dallas-based firm from 1998 to 2001. Prior to that, Sweeney developed anti-arrhythmia cardiac devices and founded two companies, Ventritex and Epicor Medical. Currently, Sweeney represents microfluidics company Fluidigm, which InterWest has backed, among other companies.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.